<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04634630</url>
  </required_header>
  <id_info>
    <org_study_id>STEMCELL/1</org_study_id>
    <nct_id>NCT04634630</nct_id>
  </id_info>
  <brief_title>The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung</brief_title>
  <official_title>The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beatrice Aramini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria di Modena</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is a prospective cohort study. The aim is to assess the relationship&#xD;
      between the presence of cancer stem-cells (CSC) and the risk of relapse in patients with&#xD;
      early and locally advanced adenocarcinoma and squamous cell carcinoma of the lung&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 17, 2017</start_date>
  <completion_date type="Actual">October 17, 2020</completion_date>
  <primary_completion_date type="Actual">October 17, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relapse Free Survival</measure>
    <time_frame>Minimum follow-up time: 1 year</time_frame>
    <description>Days from lung cancer resection to relapse</description>
  </primary_outcome>
  <enrollment type="Actual">35</enrollment>
  <condition>Lung Cancer, Nonsmall Cell</condition>
  <condition>Relapse/Recurrence</condition>
  <condition>CSC</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Exposure to lung cancer stem cells</intervention_name>
    <description>The exposure to lung cancer stem cells was measure as the percentage of Aldehyde dehydrogenase (ALDH) on all viable cells extracted from surgically resected tumor specimens</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent major lung resection by lateral thoracotomy or videothoracoscopic&#xD;
        approach for stage I, II, or IIIA adenocarcinoma or squamous cell carcinoma of the lung&#xD;
        (tumor, node, metastasis (TNM) staging system, eighth edition)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with stage I, II or IIIA adenocarcinoma of squamous cell carcinoma of the&#xD;
             lung&#xD;
&#xD;
          -  age between 18 and 85&#xD;
&#xD;
          -  R0 resection&#xD;
&#xD;
          -  availability of formalin-fixed, paraffin-embedded surgery specimen from the primary&#xD;
             tumor&#xD;
&#xD;
          -  availability of fresh surgical specimen for cytofluorimetric analysis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  incomplete resection&#xD;
&#xD;
          -  unknown tumor, node or metastasis status&#xD;
&#xD;
          -  synchronous tumors&#xD;
&#xD;
          -  previous lung cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uliano Morandi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero-Universitaria di Modena</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 12, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2020</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria di Modena</investigator_affiliation>
    <investigator_full_name>Beatrice Aramini</investigator_full_name>
    <investigator_title>Assistant Professor in Thoracic Surgery</investigator_title>
  </responsible_party>
  <keyword>Non Small Cell Lung Cancer</keyword>
  <keyword>Cancer Stem Cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

